共 50 条
- [9] Inotuzumab Ozogamicin (IO) and Donor Lymphocyte Infusion (DLI) are a Safe and Promising Combination in Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S161 - S161